Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007; 102(11), 2504-12 [Abstract]
Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 2007; 102(12), 2754-61 [Abstract]
Bentley RW, Keenan JI, Gearry RB, Kennedy MA, Barclay ML, Roberts RL. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn's disease and control subjects. Am J Gastroenterol 2007; 102, 15 [Abstract]
Gardiner SJ , Gearry R B , Roberts RL , Zhang M, Barclay ML, Begg EJ. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2007; 41(4), 719-20 [No abstract]
Aronson JK, Cohen A, Ritter JM, Begg EJ, Lewis LD, Schachter M. Editors' report for 2006. Br J Clin Pharmacol 2007; 64(3), 253-4 [Abstract]
Aronson JK, Lennard MS, Ritter JM, Begg EJ, Lewis LD, Schachter M. Editors' review of 2006 and the BJCP prize. Br J Clin Pharmacol 2007; 63(1), 1-4 [Abstract]
Vella-Brincat JW, Begg EJ, Kirkpatrick CM, Zhang M, Chambers ST, Gallagher K. Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Clin Pharmacol 2007; 63(6), 753-7 [Abstract]
Frizelle F, Barclay M. Constipation in adults. BMJ Clin Evid 2007; 2007, 1-17 [Abstract]
Doogue M, Soule S, Hunt P. Another cause of 'pseudophaeochromocytoma'-quetiapine associated with a false positive normetanephrine result (Letter). Clin Endocrinol 2007; 67(3), 472-3 [Abstract]
Gardiner SJ, Begg EJ, Sau A, Marinaki A, Gearry RB, Barclay ML. Comment re: thiopurine treatment in inflammatory bowel disease. Clin Pharmacokinet 2007; 46(9), 803-4 [Abstract]
Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflamm Bowel Dis 2007; 13(9), 1069-76 [Abstract]
Gearry RB, Roberts RL, Burt MJ, Frampton CM, Chapman BA, Collett JA, Shirley P, Allington MD, Kennedy MA, Barclay ML. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 2007; 13(10), 1220-7 [Abstract]
Brooks AJ, Begg EJ, Chapman BA, Fitzharris BM. Two cases of severe liver injury possibly related to 5-fluorouracil and calcium folinate. Intern Med J 2007; 37, 344- 5 [Abstract]
Vella-Brincat J, MacLeod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007; 21(1), 15-25 [Abstract]
Begg EJ. Adverse reactions: The Fenoterol Story (Book review). NZ Med J 2007; 120(1254), 83-5 [Abstract]
Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus Intravenous Delivery of Methylprednisolone to Cochlear Perilymph. Otol Neurotol 2007; 28(8), 1124-30 [Abstract]
Roberts RL, Gearry RB, Barclay ML, Kennedy MA. IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance. Pharmacogenomics J 2007; 7(5), 312-7 [Abstract]
Brooks AJ, Begg EJ, Zhang M, Frampton CM, Barclay ML. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease. Ther Drug Monit 2007; 29(5), 619-25 [Abstract]
Browning BL, Annese V, Barclay ML, Bingham SA, Brand S, Büning C, Castro M, Cucchiara S, et al. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet 2008; 45(1), 36-42 [Abstract]